FM Sitharaman Announces ₹10,000 Crore Bio Pharma Shakti Scheme, 1 Lakh Allied Jobs
New Delhi, february 1 In a major initiative to boost India’s biopharma sector, Finance minister Nirmala Sitharaman announced the launch of the Bio Pharma shakti Scheme with an allocation of ₹10,000 crore under the Union Budget 2026-27. This ambitious scheme aims to strengthen India’s biotechnology and pharmaceutical ecosystem and create 1 lakh allied jobs, focusing on research, manufacturing, and health innovation.
Key Highlights of the Bio Pharma shakti Scheme
Why This Scheme Matters
ConclusionThe ₹10,000 crore Bio Pharma shakti Scheme, along with the creation of 1 lakh allied jobs, represents a transformative step for India’s biopharma industry. By promoting innovation, strengthening infrastructure, and creating employment, the scheme positions india as a global leader in biotechnology, while ensuring affordable healthcare and economic growth. Disclaimer:The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of any agency, organization, employer, or company. All information provided is for general informational purposes only. While every effort has been made to ensure accuracy, we make no representations or warranties of any kind, express or implied, about the completeness, reliability, or suitability of the information contained herein. Readers are advised to verify facts and seek professional advice where necessary. Any reliance placed on such information is strictly at the reader’s own risk.
Key Highlights of the Bio Pharma shakti Scheme
- ₹10,000 Crore Investment:
- The government has earmarked ₹10,000 crore to support biopharma R&D, infrastructure, and manufacturing capacity.
- This fund will help india develop cutting-edge vaccines, biologics, and therapeutic drugs to meet both domestic and global demand.
- 1 Lakh Allied Jobs:
- The scheme is expected to generate 100,000 jobs in areas such as research, laboratory work, production, quality control, logistics, and related biotech services.
- Job creation will also focus on regional inclusion, providing employment opportunities in semi-urban and rural areas where biotech clusters are being developed.
- Support for Innovation and Startups:
- The scheme will provide funding, incubation, and mentorship for biotech startups.
- It will encourage public-private partnerships to accelerate product development and ensure that innovations reach market quickly.
- Infrastructure Development:
- Funds will be utilized to establish state-of-the-art laboratories, manufacturing units, and biotech parks across India.
- This will help scale production of vaccines, biologics, and biosimilars, reducing India’s dependency on imports and boosting exports.
- Global Competitiveness:
- The initiative positions india to become a global hub for biopharma, capable of exporting affordable vaccines and therapeutics worldwide.
- It will also encourage international collaboration, attracting foreign investment and technology transfers.
Why This Scheme Matters
- Boosting India’s Biopharma Sector:
- India already has a strong presence in generic drugs and vaccines. The Bio Pharma shakti Scheme will help the country move into high-end biologics, biosimilars, and innovative therapies.
- Creating Skilled Employment:
- With 1 lakh allied jobs, the scheme supports high-skill employment in research, manufacturing, and logistics.
- It will also promote biotech education and training programs, preparing a future-ready workforce.
- Enhancing Healthcare Access and Security:
- By increasing domestic production of medicines, vaccines, and biologics, india can improve healthcare access and reduce reliance on imports, strengthening health security.
- Economic Growth:
- Increased investment in biotech infrastructure and R&D will boost exports, attract foreign investment, and contribute significantly to India’s GDP growth.
ConclusionThe ₹10,000 crore Bio Pharma shakti Scheme, along with the creation of 1 lakh allied jobs, represents a transformative step for India’s biopharma industry. By promoting innovation, strengthening infrastructure, and creating employment, the scheme positions india as a global leader in biotechnology, while ensuring affordable healthcare and economic growth. Disclaimer:The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of any agency, organization, employer, or company. All information provided is for general informational purposes only. While every effort has been made to ensure accuracy, we make no representations or warranties of any kind, express or implied, about the completeness, reliability, or suitability of the information contained herein. Readers are advised to verify facts and seek professional advice where necessary. Any reliance placed on such information is strictly at the reader’s own risk.